Akari Therapeutics Plc also files under CLTX; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 2K | $7.52 | $13K |
| Jul 16, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 1K | $11.50 | $13K |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 15K | $16.16 | $250K |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 6K | $0.00 | $2 |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 15K | $0.00 | $6 |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 1K | $8.00 | $10K |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 6K | $16.16 | $94K |
| Jul 7, 2026 | Patel Samir Rashmikant | Director, 10% Owner | Option exercise(M) | 1K | $32.00 | $39K |
| Jun 24, 2026 | Gaslightwala Abizer | CEO, Director | Grant(A) | 6K | — | $0 |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 7K | $3.74 | $28K |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 1K | $10.02 | $13K |
| Jun 24, 2026 | Gaslightwala Abizer | CEO, Director | Grant(A) | 16K | — | $0 |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 1K | $9.32 | $13K |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 2K | $8.28 | $13K |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 3K | $5.12 | $13K |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 4K | $3.49 | $13K |
| Jun 24, 2026 | Farag Kameel D. | Interim CFO | Grant(A) | 1K | $13.00 | $13K |
| Dec 16, 2025 | Huh Hoyoung | Director, 10% Owner | Buy(P) | 619K | $0.40 | $247K |
| Dec 16, 2025 | Huh Hoyoung | Director, 10% Owner | Buy(P) | 619K | — | — |
| Dec 16, 2025 | Patel Sandip I | Director | Buy(P) | 155K | — | — |
| Dec 16, 2025 | Patel Sandip I | Director | Buy(P) | 155K | $0.40 | $62K |
| Dec 16, 2025 | Patel Sandip I | Director | Buy(P) | 247K | — | — |
| Dec 16, 2025 | Patel Sandip I | Director | Buy(P) | 247K | $0.40 | $99K |
| Dec 16, 2025 | Prudo-Chlebosz Raymond | Director | Buy(P) | 387K | $0.40 | $155K |
| Dec 16, 2025 | Prudo-Chlebosz Raymond | Director | Buy(P) | 619K | — | — |
| Dec 16, 2025 | Prudo-Chlebosz Raymond | Director | Buy(P) | 387K | — | — |
| Dec 16, 2025 | Prudo-Chlebosz Raymond | Director | Buy(P) | 619K | $0.40 | $247K |
| Dec 16, 2025 | Neal James R | Director | Buy(P) | 2K | $0.40 | $989 |
| Dec 16, 2025 | Bazemore Robert B | Director | Buy(P) | 31K | $0.40 | $12K |
| Dec 16, 2025 | Bazemore Robert B | Director | Buy(P) | 31K | — | — |
| Dec 16, 2025 | Bazemore Robert B | Director | Buy(P) | 124K | $0.40 | $49K |
| Dec 16, 2025 | Bazemore Robert B | Director | Buy(P) | 124K | — | — |
| Dec 16, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 773K | — | — |
| Dec 16, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 309K | — | — |
| Dec 16, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 309K | $0.40 | $124K |
| Dec 16, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 773K | $0.40 | $309K |
| Dec 16, 2025 | Patel Samir Rashmikant | Director, 10% Owner | Buy(P) | 232K | — | — |
| Dec 16, 2025 | Patel Samir Rashmikant | Director, 10% Owner | Buy(P) | 619K | $0.40 | $247K |
| Dec 16, 2025 | Patel Samir Rashmikant | Director, 10% Owner | Buy(P) | 619K | — | — |
| Dec 16, 2025 | Patel Samir Rashmikant | Director, 10% Owner | Buy(P) | 232K | $0.40 | $93K |
| Dec 16, 2025 | Farag Kameel D. | Interim CFO | Buy(P) | 25K | $0.40 | $10K |
| Dec 16, 2025 | Farag Kameel D. | Interim CFO | Buy(P) | 25K | — | — |
| Dec 16, 2025 | Huh Hoyoung | Director, 10% Owner | Buy(P) | 3.1M | — | — |
| Dec 16, 2025 | Huh Hoyoung | Director, 10% Owner | Buy(P) | 3.1M | $0.40 | $1.2M |
| Dec 16, 2025 | Neal James R | Director | Buy(P) | 2K | — | — |
| Dec 16, 2025 | Neal James R | Director | Buy(P) | 3K | — | — |
| Dec 16, 2025 | Neal James R | Director | Buy(P) | 3K | $0.40 | $1K |
| Nov 1, 2025 | Farag Kameel D. | Interim CFO | Grant(A) | 27K | $0.75 | $20K |
| Nov 1, 2025 | Farag Kameel D. | Interim CFO | Grant(A) | 32K | $0.75 | $24K |
| Oct 22, 2025 | Farag Kameel D. | Interim CFO | Grant(A) | 6K | $0.74 | $5K |
| Aug 25, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 3K | $0.90 | $3K |
| Aug 22, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 8K | $0.93 | $7K |
| Aug 21, 2025 | Gaslightwala Abizer | CEO, Director | Buy(P) | 10K | $0.94 | $9K |
| Jun 24, 2025 | Gaslightwala Abizer | President & CEO, Director | Buy(P) | 5K | $1.16 | $6K |
| Jun 23, 2025 | Gaslightwala Abizer | President & CEO, Director | Buy(P) | 943 | $1.15 | $1K |
| Jun 20, 2025 | Gaslightwala Abizer | President & CEO, Director | Buy(P) | 10K | $1.20 | $12K |
| Jun 17, 2025 | Gaslightwala Abizer | President & CEO, Director | Buy(P) | 15K | $1.20 | $18K |
| Jun 13, 2025 | Gaslightwala Abizer | CEO, Director | Grant(A) | 25K | $1.19 | $30K |
| Jun 12, 2025 | Gaslightwala Abizer | CEO, Director | Grant(A) | 20K | $1.23 | $25K |
| Jun 10, 2025 | Gaslightwala Abizer | CEO, Director | Grant(A) | 20K | $1.27 | $25K |
| Mar 20, 2025 | Neal James R | Director | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Gaslightwala Abizer | Director | Grant(A) | 1.1M | — | $0 |
| Mar 20, 2025 | Gaslightwala Abizer | Director | Grant(A) | 600K | — | $0 |
| Mar 20, 2025 | Hombeck Torsten | CFO | Grant(A) | 300K | — | $0 |
| Mar 20, 2025 | Hombeck Torsten | CFO | Grant(A) | 200K | — | $0 |
| Mar 20, 2025 | Patel Sandip I | Director | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Patel Sandip I | Director | Grant(A) | 225K | — | $0 |
| Mar 20, 2025 | Huh Hoyoung | Director, 10% Owner | Grant(A) | 225K | — | $0 |
| Mar 20, 2025 | Huh Hoyoung | Director, 10% Owner | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Prudo-Chlebosz Raymond | Director | Grant(A) | 225K | — | $0 |
| Mar 20, 2025 | Prudo-Chlebosz Raymond | Director | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Patel Samir Rashmikant | Director | Grant(A) | 225K | — | $0 |
| Mar 20, 2025 | Patel Samir Rashmikant | Director | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Bazemore Robert B | Director | Grant(A) | 225K | — | $0 |
| Mar 20, 2025 | Bazemore Robert B | Director | Grant(A) | 175K | — | $0 |
| Mar 20, 2025 | Neal James R | Director | Grant(A) | 225K | — | $0 |
| Mar 6, 2025 | Patel Samir Rashmikant | Director | Grant(A) | 406K | $1.12 | $455K |
| Mar 6, 2025 | Patel Samir Rashmikant | Director | Grant(A) | 406K | $1.12 | $455K |
| Mar 6, 2025 | Huh Hoyoung | Director, 10% Owner | Grant(A) | 893K | $1.12 | $1000K |
| Mar 6, 2025 | Huh Hoyoung | Director, 10% Owner | Grant(A) | 893K | $1.12 | $1000K |
| Mar 6, 2025 | Huh Hoyoung | Director, 10% Owner | Grant(A) | 893K | $1.12 | $1000K |
| Mar 6, 2025 | Prudo-Chlebosz Raymond | Director | Grant(A) | 446K | $1.12 | $500K |
| Mar 6, 2025 | Patel Sandip I | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Patel Sandip I | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Neal James R | Director | Grant(A) | 4K | $1.12 | $5K |
| Mar 6, 2025 | Patel Sandip I | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Neal James R | Director | Grant(A) | 4K | $1.12 | $5K |
| Mar 6, 2025 | Neal James R | Director | Grant(A) | 4K | $1.12 | $5K |
| Mar 6, 2025 | Gaslightwala Abizer | Director | Grant(A) | 134K | $1.12 | $150K |
| Mar 6, 2025 | Gaslightwala Abizer | Director | Grant(A) | 134K | $1.12 | $150K |
| Mar 6, 2025 | Gaslightwala Abizer | Director | Grant(A) | 134K | $1.12 | $150K |
| Mar 6, 2025 | Bazemore Robert B | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Bazemore Robert B | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Bazemore Robert B | Director | Grant(A) | 45K | $1.12 | $50K |
| Mar 6, 2025 | Prudo-Chlebosz Raymond | Director | Grant(A) | 446K | $1.12 | $500K |
| Mar 6, 2025 | Prudo-Chlebosz Raymond | Director | Grant(A) | 446K | $1.12 | $500K |
| Mar 6, 2025 | Patel Samir Rashmikant | Director | Grant(A) | 406K | $1.12 | $455K |
| Jan 10, 2025 | Gaslightwala Abizer | Director | Grant(A) | 12K | $1.22 | $14K |
| Jan 10, 2025 | Hombeck Torsten | CFO | Grant(A) | 200 | $1.22 | $244 |
| Jan 9, 2025 | Neal James R | Director | Grant(A) | 8.0M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Akari Therapeutics Plc, SEC CIK 0001541157. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AKTX and shows every filing by that issuer (also filed as CLTX).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AKTX